← Back to catalogue
ASAHI Peripheral Guide Wire ASAHI Halberd
EUDAMEDClass IIa (EU MDR)
Ref PHW14R201PRef PHW14R201P
Identity
- Trade Name
- ASAHI Peripheral Guide Wire ASAHI Halberd EUDAMEDHalberd EUDAMED
- Device Name
- ASAHI Peripheral Guide Wire EUDAMEDPeripheral Guide Wire Astato 30, Astato XS 20, Astato XS 40, Halberd, ASAHI Gaia PV, Gladius, Gladius MG14 PV, Gladius MG14 PV ES, Gladius MG18 PV ES EUDAMED
- Model / Reference
- PHW14R201P EUDAMED
Identifiers
- Primary DI / UDI-DI
- 04547327106474 EUDAMED
- Basic UDI-DI
- B-04547327106474 EUDAMED4547327DGW010NY EUDAMED
- EMDN Code
- C04020201 PERIPHERAL VASCULAR THERAPEUTIC GUIDEWIRES, HYDROPHILIC EUDAMED
Classification
- Device Class
- Class IIa EUDAMED
- Market of Registration
- Austria EUDAMED
Clinical & Handling
Sterile
Yes
EUDAMED
Implantable
No
EUDAMED
Reusable
No
EUDAMED
Contains Latex
No
EUDAMED
Reprocessed
No
EUDAMED
CMR Substance
No
EUDAMEDEUDAMED
Human-derived
No
EUDAMED
Human Tissues
No
EUDAMED
Animal Tissues
No
EUDAMED
Endocrine Disruptor
No
EUDAMED
Administering Medicine
No
EUDAMED
Measuring Function
No
EUDAMED
Incorporates Medicinal Product
No
EUDAMED
ASAHI Peripheral Guide Wire ASAHI Halberd by Asahi Intecc Co., Ltd. — Class IIa — MDR, MDD — listed in EUDAMED — regulatory data on deviCERTS
Authorization Coverage (European Union — 27 member states)
Regulatory Authorizations
European Union Active
CE/MDR
European Union Active
CE/MDD
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| EUDAMED | European Union | CE/MDR | B-04547327106474 | Class IIa | Active |
| EUDAMED | European Union | CE/MDD | B-04547327106474 | Class IIa | Active |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- Asahi Intecc Co., Ltd.
- EUDAMED SRN
- JP-MF-000010199
- Authorised Representative
- Emergo Europe B.V. NL-AR-000000116
Sources (2)
- EUDAMED 0226afe8-e70d-4f62-9098-7d5387e12c72 61 fields · synced Jul 20, 2026
- EUDAMED 2d099e62-415b-479f-a715-25d6e7d1397f 61 fields · synced May 18, 2026